NCT05384145 (COAST-AL) is a NA clinical trial of COAST-AL in HIV, sponsored by University of Alabama at Birmingham.

Who is sponsoring NCT05384145?

NCT05384145 is sponsored by University of Alabama at Birmingham.

What drugs are being tested in NCT05384145?

Interventions in NCT05384145: COAST-AL.

What condition does NCT05384145 study?

NCT05384145 studies HIV, HIV Linkage to Care, HIV Testing, HIV Treatment.

Is NCT05384145 still recruiting?

NCT05384145 is currently recruiting now. Last updated 6 April 2026.

Last reviewed 2026-04-06 · How we verify

NCT05384145: COAST-AL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

Recruiting now NA Last updated 6 April 2026

What this trial tests

NA trial testing COAST-AL in HIV in 80 participants. Currently enrolling.

Timeline

27 March 2024

Primary endpoint
31 May 2027

31 December 2027

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	80
Start date	27 March 2024
Primary completion	31 May 2027
Estimated completion	31 December 2027
Sites	1 location across United States

Drugs / interventions tested

COAST-AL

Conditions studied

HIV — all drugs for HIV →
HIV Linkage to Care — all drugs for HIV Linkage to Care →
HIV Testing — all drugs for HIV Testing →
HIV Treatment — all drugs for HIV Treatment →

Sponsor

University of Alabama at Birmingham

Who can join

13 and older, any sex, with HIV or HIV Linkage to Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to adapt and evaluate a combination intervention that includes: (1) a data-driven approach to directed community-based HIV testing to areas with high need, (2) Project Connect to expedite linkage to care at time of diagnosis, (3) and a Rapid ART (antiretroviral therapy)Start program, all in Mobile County Health Department (MCHD) jurisdictions in Alabama.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Integrating existing and novel methods to understand organizational context: A case study of an academic-public health department partnership.
Hearld LR, Pratt MC, Smith D, Parman M, et al · · 2024 · cited 1× · PMID 39481580 · DOI 10.1016/j.annepidem.2024.10.005

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05384145 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 6 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05384145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing